We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.'s share was trading at $750.11 as of December 1st. REGN’s trailing and forward P/E were 18.70 and 18.52 respectively according to Yahoo Finance.
[caption id="attachment_374942" align="aligncenter" width="750"]Regeneron Pharmaceuticals (REGN) reported its third-quarter earnings, again outperforming expectations...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.